secwatch.observer — SEC 8-K summary
======================================

Issuer:     DT Cloud Star Acquisition Corp (DTSQ)
CIK:        0002017950
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001493152-26-005020
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DT Cloud Star to merge with PrimeGen US in $1.5B SPAC deal; target advances stem cell therapy
--------------------------------------------------------------------------------

- Deal implies ~$1.5B equity value for PrimeGen US; expected to close in H2 2026 subject to approvals.
- PrimeGen's Triple Activated MSC platform targets acute liver failure; completed FDA Pre-IND meeting Dec 17, 2025.
- Combined company to list on Nasdaq under a new ticker; proceeds to fund clinical development and commercialization.
- Transaction requires stockholder approvals, HSR clearance, and minimum cash conditions; closing not guaranteed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/0001493152-26-005020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer